Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
Clinical trial NCT02385136 · UNKNOWN
Trial details
- NCT number
- NCT02385136
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.